Goldman Sachs’s DaVita DVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-23,300
| Closed | -$3.48M | – | 6140 |
|
|
2024
Q4 | $3.48M | Hold |
23,300
| – | – | ﹤0.01% | 3803 |
|
|
2024
Q3 | $3.82M | Hold |
23,300
| – | – | ﹤0.01% | 3596 |
|
|
2024
Q2 | $3.23M | Hold |
23,300
| – | – | ﹤0.01% | 3555 |
|
|
2024
Q1 | $3.22M | Hold |
23,300
| – | – | ﹤0.01% | 3487 |
|
|
2023
Q4 | $2.44M | Buy |
+23,300
| New | +$2.15M | ﹤0.01% | 3767 |
|
|
2022
Q3 | – | Sell |
-12,500
| Closed | -$1M | – | 6324 |
|
|
2022
Q2 | $1M | Buy |
+12,500
| New | +$1.27M | ﹤0.01% | 4604 |
|
|
2021
Q1 | – | Sell |
-38,500
| Closed | -$4.52M | – | 6123 |
|
|
2020
Q4 | $4.52M | Buy |
38,500
+500
| +1% | +$50.9K | ﹤0.01% | 3078 |
|
|
2020
Q3 | $3.25M | Sell |
38,000
-12,000
| -24% | -$1.03M | ﹤0.01% | 3229 |
|
|
2020
Q2 | $3.96M | Buy |
50,000
+25,000
| +100% | +$1.95M | ﹤0.01% | 2972 |
|
|
2020
Q1 | $1.9M | Hold |
25,000
| – | – | ﹤0.01% | 3341 |
|
|
2019
Q4 | $1.88M | Sell |
25,000
-31,900
| -56% | -$2.12M | ﹤0.01% | 3693 |
|
|
2019
Q3 | $3.25M | Buy |
56,900
+36,900
| +185% | +$2.14M | ﹤0.01% | 3179 |
|
|
2019
Q2 | $1.13M | Buy |
20,000
+10,400
| +108% | +$539K | ﹤0.01% | 3919 |
|
|
2019
Q1 | $521K | Hold |
9,600
| – | – | ﹤0.01% | 4404 |
|
|
2018
Q4 | $494K | Sell |
9,600
-90,400
| -90% | -$5.79M | ﹤0.01% | 4370 |
|
|
2018
Q3 | $7.16M | Buy |
+100,000
| New | +$7.07M | ﹤0.01% | 2710 |
|
|
2018
Q2 | – | Sell |
-7,300
| Closed | -$481K | – | 5736 |
|
|
2018
Q1 | $481K | Sell |
7,300
-122,700
| -94% | -$9.01M | ﹤0.01% | 4520 |
|
|
2017
Q4 | $9.39M | Sell |
130,000
-229,600
| -64% | -$14.1M | ﹤0.01% | 2500 |
|
|
2017
Q3 | $21.4M | Buy |
359,600
+135,200
| +60% | +$8.14M | 0.01% | 1921 |
|
|
2017
Q2 | $14.5M | Buy |
224,400
+213,100
| +1,886% | +$14.1M | ﹤0.01% | 2220 |
|
|
2017
Q1 | $768K | Sell |
11,300
-1,300
| -10% | -$86.1K | ﹤0.01% | 4623 |
|
|
2016
Q4 | $809K | Buy |
12,600
+11,100
| +740% | +$691K | ﹤0.01% | 4633 |
|
|
2016
Q3 | $99K | Buy |
1,500
+1,400
| +1,400% | +$98.6K | ﹤0.01% | 6229 |
|
|
2016
Q2 | $8K | Sell |
100
-200
| -67% | -$15.1K | ﹤0.01% | 6884 |
|
|
2016
Q1 | $22K | Sell |
300
-2,300
| -88% | -$155K | ﹤0.01% | 6718 |
|
|
2015
Q4 | $181K | Sell |
2,600
-17,400
| -87% | -$1.27M | ﹤0.01% | 5783 |
|
|
2015
Q3 | $1.45M | Sell |
20,000
-27,200
| -58% | -$2.11M | ﹤0.01% | 4114 |
|
|
2015
Q2 | $3.75M | Sell |
47,200
-531,400
| -92% | -$43.6M | ﹤0.01% | 3207 |
|
|
2015
Q1 | $47M | Buy |
578,600
+558,400
| +2,764% | +$42.9M | 0.02% | 1148 |
|
|
2014
Q4 | $1.53M | Sell |
20,200
-18,900
| -48% | -$1.42M | ﹤0.01% | 4120 |
|
|
2014
Q3 | $2.86M | Sell |
39,100
-5,100
| -12% | -$373K | ﹤0.01% | 3574 |
|
|
2014
Q2 | $3.2M | Sell |
44,200
-38,900
| -47% | -$2.71M | ﹤0.01% | 3508 |
|
|
2014
Q1 | $5.72M | Buy |
83,100
+43,500
| +110% | +$2.89M | ﹤0.01% | 2868 |
|
|
2013
Q4 | $2.51M | Buy |
39,600
+38,600
| +3,860% | +$2.27M | ﹤0.01% | 3842 |
|
|
2013
Q3 | $57K | Sell |
1,000
-334,800
| -100% | -$19.2M | ﹤0.01% | 6281 |
|
|
2013
Q2 | $20.3M | Buy |
+335,800
| New | +$21M | 0.01% | 1536 |
|
Other funds holding DVA
VCM
VPM
Goldman Sachs's DVA Position: Q1 2026 in Review
Goldman Sachs increased its DaVita (DVA) stake by 44% in Q1 2026, buying an estimated $18.5M and bringing the position to 447,422 shares worth $68.8M. The position accounts for 0.01% of the portfolio, ranked #1317.
Goldman Sachs first reported a position in DVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $109M in Q4 2013. 583 funds tracked by Wall St. Rank hold DVA as of Q1 2026.
- Goldman Sachs held 447,422 shares of DaVita worth $68.8M as of Q1 2026.
- Goldman Sachs bought 136,577 DaVita shares in Q1 2026, an estimated $18.5M.
- DaVita made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1317 holding.
- Goldman Sachs first reported a position in DaVita in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's DaVita position peaked at $109M in Q4 2013.
- 583 funds tracked by Wall St. Rank held DaVita as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.